DK1149840T5 - Fremgangsmåde til fremstilling af drospirenon - Google Patents

Fremgangsmåde til fremstilling af drospirenon

Info

Publication number: DK1149840T5
Authority: DK; Denmark
Prior art keywords: 15beta; 16beta; 6beta; 7beta; 17alpha
Prior art date: 1996-08-12

Application number

DK01250277.9T

Other languages

English (en)

Other versions

DK1149840T4 (da

DK1149840T3 (da

Inventor

Klaus Nickisch

Joerg-Thorsten Mohr

Original Assignee

Bayer Pharma AG

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-08-12

Filing date

1997-08-11

Publication date

2013-09-30

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7803224&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1149840(T5) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1997-08-11 Application filed by Bayer Pharma AG filed Critical Bayer Pharma AG

2009-04-27 Application granted granted Critical

2009-04-27 Publication of DK1149840T3 publication Critical patent/DK1149840T3/da

2013-07-01 Publication of DK1149840T4 publication Critical patent/DK1149840T4/da

2013-09-30 Publication of DK1149840T5 publication Critical patent/DK1149840T5/da

Links

METQSPRSQINEEU-UHFFFAOYSA-N dihydrospirorenone Natural products CC12CCC(C3(CCC(=O)C=C3C3CC33)C)C3C1C1CC1C21CCC(=O)O1 METQSPRSQINEEU-UHFFFAOYSA-N 0.000 title abstract 3
METQSPRSQINEEU-HXCATZOESA-N drospirenone Chemical compound C([C@]12[C@H]3C[C@H]3[C@H]3[C@H]4[C@@H]([C@]5(CCC(=O)C=C5[C@@H]5C[C@@H]54)C)CC[C@@]31C)CC(=O)O2 METQSPRSQINEEU-HXCATZOESA-N 0.000 title abstract 3
229960004845 drospirenone Drugs 0.000 title abstract 2
239000000543 intermediate Substances 0.000 abstract 1
150000003303 ruthenium Chemical class 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
- C07J53/002—Carbocyclic rings fused
- C07J53/004—3 membered carbocyclic rings
- C07J53/007—3 membered carbocyclic rings in position 6-7
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
- C07J53/002—Carbocyclic rings fused
- C07J53/004—3 membered carbocyclic rings
- C07J53/008—3 membered carbocyclic rings in position 15/16

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Steroid Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Pyrane Compounds (AREA)
Fats And Perfumes (AREA)
Polyesters Or Polycarbonates (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)

DK01250277.9T 1996-08-12 1997-08-11 Fremgangsmåde til fremstilling af drospirenon DK1149840T5 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE19633685A DE19633685C1 (de)	1996-08-12	1996-08-12	Verfahren zur Herstellung von Drospirenon (6beta,7beta;15 beta,16beta-Dimethyl-en-3-oxo-17alpha-pregn-4-en-21,17-carbolacton, DRSP) sowie 7alpha-(3-Hydroxy-1-propyl)-6beta,7beta;15beta, 16beta-dimethylen-5beta-androstan-3beta,5,17beta-triol (ZK 92836) und 6beta,7beta;15beta,16beta-dimethylen-5beta-hydroxy-3-oxo-17alpha-androstan-21,17-carbolacton (90965) als Zwischenprodukte des Verfahrens
PCT/EP1997/004342 WO1998006738A1 (de)	1996-08-12	1997-08-11	Verfahren zur herstellung von drospirenon und zwischenprodukten davon

Publications (3)

Publication Number	Publication Date
DK1149840T3 DK1149840T3 (da)	2009-04-27
DK1149840T4 DK1149840T4 (da)	2013-07-01
DK1149840T5 true DK1149840T5 (da)	2013-09-30

Family

ID=7803224

Family Applications (4)

Application Number	Title	Priority Date	Filing Date
DK01250278.7T DK1149841T3 (da)	1996-08-12	1997-08-11	Fremgangsmåde til fremstilling af 6beta, 7beta; 15beta, 16beta-dimethylen-5beta-hydroxy-3-oxo-17alfa-androstan-21,17-carbonlacton
DK97937562T DK0918791T3 (da)	1996-08-12	1997-08-11	Fremgangsmåde til fremstilling af drospirenon og mellemprodukter deraf
DK01250277.9T DK1149840T5 (da)	1996-08-12	1997-08-11	Fremgangsmåde til fremstilling af drospirenon
DK09100011.7T DK2168974T3 (da)	1996-08-12	1997-08-11	Fremgangsmåde til fremstilling af drospirenon (6SS, 7ß, 15SS, 16ss-dimethylen-3-oxo-17alpha-pregn-4-en-21,17-carbolactoner, DRSP)

Family Applications Before (2)

Application Number	Title	Priority Date	Filing Date
DK01250278.7T DK1149841T3 (da)	1996-08-12	1997-08-11	Fremgangsmåde til fremstilling af 6beta, 7beta; 15beta, 16beta-dimethylen-5beta-hydroxy-3-oxo-17alfa-androstan-21,17-carbonlacton
DK97937562T DK0918791T3 (da)	1996-08-12	1997-08-11	Fremgangsmåde til fremstilling af drospirenon og mellemprodukter deraf

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
DK09100011.7T DK2168974T3 (da)	1996-08-12	1997-08-11	Fremgangsmåde til fremstilling af drospirenon (6SS, 7ß, 15SS, 16ss-dimethylen-3-oxo-17alpha-pregn-4-en-21,17-carbolactoner, DRSP)

Country Status (26)

Country	Link
US (2)	US6121465A (da)
EP (4)	EP1149841B1 (da)
JP (1)	JP3333524B2 (da)
KR (1)	KR100473297B1 (da)
CN (1)	CN1158300C (da)
AT (3)	ATE215557T1 (da)
AU (1)	AU729149B2 (da)
BG (1)	BG62776B1 (da)
BR (1)	BR9711060A (da)
CA (1)	CA2261137C (da)
CZ (1)	CZ297255B6 (da)
DE (4)	DE19633685C1 (da)
DK (4)	DK1149841T3 (da)
EA (1)	EA001947B1 (da)
ES (4)	ES2438941T3 (da)
HU (1)	HU223106B1 (da)
IL (1)	IL127963A (da)
IS (1)	IS2100B (da)
NZ (1)	NZ333697A (da)
PL (1)	PL187474B1 (da)
PT (4)	PT918791E (da)
SI (3)	SI1149840T2 (da)
SK (1)	SK283546B6 (da)
TR (1)	TR199900262T2 (da)
UA (1)	UA55423C2 (da)
WO (1)	WO1998006738A1 (da)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE19633685C1 (de)	1996-08-12	1997-10-09	Schering Ag	Verfahren zur Herstellung von Drospirenon (6beta,7beta;15 beta,16beta-Dimethyl-en-3-oxo-17alpha-pregn-4-en-21,17-carbolacton, DRSP) sowie 7alpha-(3-Hydroxy-1-propyl)-6beta,7beta;15beta, 16beta-dimethylen-5beta-androstan-3beta,5,17beta-triol (ZK 92836) und 6beta,7beta;15beta,16beta-dimethylen-5beta-hydroxy-3-oxo-17alpha-androstan-21,17-carbolacton (90965) als Zwischenprodukte des Verfahrens
US6787531B1 (en) *	1999-08-31	2004-09-07	Schering Ag	Pharmaceutical composition for use as a contraceptive
EP1598069B1 (en)	1999-08-31	2009-04-22	Bayer Schering Pharma Aktiengesellschaft	Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive
EP2305267A3 (en)	1999-08-31	2011-08-17	Bayer Schering Pharma Aktiengesellschaft	Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive
IL150775A0 (en) *	2000-01-18	2003-02-12	Schering Ag	Drospirenone for hormone replacement therapy
US20020132801A1 (en) *	2001-01-11	2002-09-19	Schering Aktiengesellschaft	Drospirenone for hormone replacement therapy
EP1406634A1 (en)	2001-07-13	2004-04-14	Schering Aktiengesellschaft	Combination of drospirenone and an estrogen sulphamate for hrt
CA2483554A1 (en) *	2002-04-26	2003-11-06	Schering Aktiengesellschaft	Treatment of hypertension in women receiving hormone replacement therapy
US7786101B2 (en)	2002-11-05	2010-08-31	Bayer Schering Pharma Ag	Cardiovascular protection using anti-aldosteronic progestins
CL2004000574A1 (es) *	2003-03-21	2005-02-11	Pharmacia Corp Sa Organizada B	Proceso para preparar un compuesto 17-espirolactona o la sal de lactona abierta por carbonilacion del correspondiente 17-alquenil o alquinil derivado, los intermediarios que se usan y su proceso de obtencion.
ITMI20040367A1 (it) *	2004-03-01	2004-06-01	Ind Chimica Srl	Processo per la preparazione di drospirenone
HUP0402465A2 (en) *	2004-11-30	2006-07-28	Richter Gedeon Vegyeszet	Industrial process for preparing 17-hydroxy-6-betha, 7-betha, 15-betha, 16-betha-bis-methylene-3-oxo-17-alpha-pregn-4-ene-21-carboxylic acid gamma lacton and the main intermediates of the process
HUP0402466A2 (en) *	2004-11-30	2006-07-28	Richter Gedeon Vegyeszet	Industrial process for preparing 17-hydroxy-6-betha, 7-betha, 15-betha, 16-betha-bis-methylene-3-oxo-17-alpha-pregn-4-ene-21-carboxylic acid gamma lacton and the main, intermediates of the process
DE102004058300B4 (de) *	2004-12-02	2016-09-15	Austriamicrosystems Ag	Schaltungsanordnung zur Erzeugung eines komplexen Signals und Verwendung in einem Hochfrequenz-Sender oder -Empfänger
ITMI20042338A1 (it) *	2004-12-06	2005-03-06	Ind Chimica Srl	Processo per la preparazione di drospirenone
HUE038504T2 (hu) *	2005-07-21	2018-10-29	Bayer Ip Gmbh	Eljárás 3-oxo-pregn-4-én-21,17-karbolaktonok elõállítására 17-(3-hidroxipropil)-3,17,dihidroxiandrosztánok fémmentes oxidációjával
US7319154B2 (en)	2005-07-21	2008-01-15	Bayer Schering Pharma Ag	Process for the production of 3-oxo-pregn-4-ene-21, 17-carbolactones by the metal free oxidation of 17-(3-hydroxypropyl)-3, 17-dihydroxyandrostanes
PT1746101E (pt) *	2005-07-21	2008-10-27	Bayer Schering Pharma Ag	Processo para o fabrico de 3-oxo-pregn-4-eno-21,17-carbolactonas por meio de oxidação isenta de metais de 17-(3-hidroxipropil)-3,17-di-hidroxiandrostanos
US20070255381A1 (en)	2006-04-27	2007-11-01	Peter Meyer	Electrode pad packaging systems and methods
EP1902711A1 (en) *	2006-09-20	2008-03-26	KAIROSmed GmbH	Oral modified release formulations containing Drospirenon and 8-Prenylnaringenin for use in Hormone Replacement Therapy (HRT)
WO2008137050A2 (en) *	2007-05-01	2008-11-13	Sicor Inc.	A process for preparing drospirenone and intermediate thereof
DE102007030596B3 (de) *	2007-06-28	2009-03-12	Bayer Schering Pharma Aktiengesellschaft	Verfahren zur Herstellung von 17-(3-Hydroxypropyl)-17-hydroxysteroiden
WO2009111574A2 (en) *	2008-03-05	2009-09-11	Evestra, Inc.	BISMETHYLENE-17α CARBOLACTONES AND RELATED USES
EP2367808A4 (en) *	2008-11-25	2012-05-09	Evestra Inc	PROGESTATIVE 3- (6,6-ETHYLENE-17b-HYDROXY-3-OXO-17a-PREGNA-4-EN-17a-YL) PROPIONIC ACID g-LACTONE
EP2398467A1 (en)	2009-02-18	2011-12-28	Bayer Pharma Aktiengesellschaft	Particles comprising drospirenone encapsulated in a polymer
WO2010094623A1 (en)	2009-02-18	2010-08-26	Bayer Schering Pharma Aktiengesellschaft	Formulation comprising drospirenone for subcutaneous or intramuscular administration
US8334375B2 (en) *	2009-04-10	2012-12-18	Evestra, Inc.	Methods for the preparation of drospirenone
ES2432063T3 (es) *	2009-06-16	2013-11-29	Crystal Pharma, S.A.U.	Procedimiento para la obtención de 17-espirolactonas en esteroides
DE102009031909B4 (de)	2009-07-01	2017-02-09	Heyl Chemisch-Pharmazeutische Fabrik Gmbh & Co. Kg	Verfahren zur Herstellung von Drospirenon aus Prasteron
EP2548881B1 (en) *	2010-03-16	2014-12-17	Taizhou Taifa Pharmaceuticals Co., Ltd	Preparation method of drospirenone
CN101830959B (zh) *	2010-05-27	2012-07-18	杭州龙山化工有限公司	一种曲螺酮的合成方法
AR081670A1 (es)	2010-06-29	2012-10-10	Leon Farma Sa Lab	Composicion farmaceutica que comprende drospirenona y kit anticonceptivo
US10849857B2 (en)	2010-07-28	2020-12-01	Laboratorios Leon Farma Sa	Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
US11351122B1 (en)	2010-07-28	2022-06-07	Laboratorios Leon Farma Sa	Synthetic progestogens and pharmaceutical compositions comprising the same
US9603860B2 (en)	2010-07-28	2017-03-28	Laboratorios Leon Farma Sa	Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
EP2415778B1 (en)	2010-08-03	2013-05-15	Newchem S.p.A.	Methods for the preparation of Drospirenone and intermediates thereof
WO2012107513A1 (en)	2011-02-10	2012-08-16	Crystal Pharma, S.A.U.	Process for obtaining drospirenone
ITMI20111383A1 (it)	2011-07-25	2013-01-26	Ind Chimica Srl	Processo per la preparazione di drospirenone
AU2012331089A1 (en) *	2011-11-04	2014-05-22	Bayer Intellectual Property Gmbh	18-methyl-6,7-methylene-3-oxo-17-pregn-4-ene-21,17beta-carbolactones, pharmaceutical preparations comprising said compounds and use thereof in the treatment of endometriosis
WO2013076118A1 (en)	2011-11-22	2013-05-30	Industriale Chimica S.R.L.	Process for the preparation of drospirenone
EP2597101A1 (en)	2011-11-22	2013-05-29	Industriale Chimica S.R.L.	Process for the preparation of drospirenone
EP2958929B1 (en)	2013-02-20	2017-09-13	Industriale Chimica S.R.L.	Process for the preparation of drospirenone
PT2984100T (pt)	2013-04-12	2017-07-14	Ind Chimica Srl	Processo para a preparação de drospirenona
DK3313408T3 (da)	2015-06-23	2024-01-29	Laboratorios Leon Farma Sa	Drospirenon-baseret svangerskabsforebyggende middel til en kvindelig patient, som lider af overvægt
EP3108889A1 (en)	2015-06-23	2016-12-28	Philippe Perrin	Drospirenone-based contraceptive for a female patient affected with excess weight
CN113387993A (zh) *	2021-07-06	2021-09-14	江西百思康瑞药业有限公司	一种屈螺酮的合成方法
EP4134082A1 (en)	2021-08-12	2023-02-15	Chemo Research, S.L.	Method for treating endometriosis and providing effective contraception
WO2023152658A1 (en)	2022-02-10	2023-08-17	Lupin Limited	Slow release drospirenone tablet composition
AR128632A1 (es)	2022-03-01	2024-05-29	Chemo Res S L	Anticonceptivo oral masticable de drospirenona

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2652761C2 (de)	1976-11-16	1985-11-21	Schering AG, 1000 Berlin und 4709 Bergkamen	15,16-Methylen-Spirolactone, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE3022337A1 (de) *	1980-06-11	1982-01-07	Schering Ag Berlin Und Bergkamen, 1000 Berlin	Praeparate zur kontrazeption und zur behandlung gynaekologischer stoerungen
DE3042136A1 (de) *	1980-11-03	1982-06-09	Schering Ag, 1000 Berlin Und 4619 Bergkamen	Verfahren zur herstellung von 3 (beta), 7 (beta) -dihydroxy- (delta) (pfeil hoch)5(pfeil hoch) -steroiden
EP0075189B1 (en) *	1981-09-21	1985-08-28	Schering Aktiengesellschaft	3-beta,7-beta,15-alpha-trihydroxy-5-androsten-17-one, its 3,15-dipivalate, and its preparation
DE3414508A1 (de) *	1984-04-13	1985-10-24	Schering AG, 1000 Berlin und 4709 Bergkamen	Mehrfach tritiierte steroid-20.17-spirolactone und ihre verwendung als tracersubstanzen
DE3626838A1 (de) *	1986-08-08	1988-02-11	Schering Ag	Verfahren zur herstellung von 17(alpha)-pregnan-21,17-carbolactonen
US5106995A (en) *	1989-05-05	1992-04-21	Isp Investments Inc.	Production of lactones from diols
DE19633685C1 (de)	1996-08-12	1997-10-09	Schering Ag	Verfahren zur Herstellung von Drospirenon (6beta,7beta;15 beta,16beta-Dimethyl-en-3-oxo-17alpha-pregn-4-en-21,17-carbolacton, DRSP) sowie 7alpha-(3-Hydroxy-1-propyl)-6beta,7beta;15beta, 16beta-dimethylen-5beta-androstan-3beta,5,17beta-triol (ZK 92836) und 6beta,7beta;15beta,16beta-dimethylen-5beta-hydroxy-3-oxo-17alpha-androstan-21,17-carbolacton (90965) als Zwischenprodukte des Verfahrens

1996
- 1996-08-12 DE DE19633685A patent/DE19633685C1/de not_active Expired - Fee Related
1997
- 1997-08-11 DK DK01250278.7T patent/DK1149841T3/da active
- 1997-08-11 WO PCT/EP1997/004342 patent/WO1998006738A1/de not_active Ceased
- 1997-08-11 EP EP01250278A patent/EP1149841B1/de not_active Expired - Lifetime
- 1997-08-11 NZ NZ333697A patent/NZ333697A/xx not_active IP Right Cessation
- 1997-08-11 AT AT97937562T patent/ATE215557T1/de active
- 1997-08-11 ES ES09100011.7T patent/ES2438941T3/es not_active Expired - Lifetime
- 1997-08-11 IL IL12796397A patent/IL127963A/en not_active IP Right Cessation
- 1997-08-11 DK DK97937562T patent/DK0918791T3/da active
- 1997-08-11 AT AT01250278T patent/ATE446966T1/de active
- 1997-08-11 SI SI9730786T patent/SI1149840T2/sl unknown
- 1997-08-11 US US09/242,334 patent/US6121465A/en not_active Expired - Lifetime
- 1997-08-11 CA CA002261137A patent/CA2261137C/en not_active Expired - Lifetime
- 1997-08-11 AU AU40144/97A patent/AU729149B2/en not_active Expired
- 1997-08-11 TR TR1999/00262T patent/TR199900262T2/xx unknown
- 1997-08-11 ES ES01250278T patent/ES2335860T3/es not_active Expired - Lifetime
- 1997-08-11 SI SI9730350T patent/SI0918791T1/xx unknown
- 1997-08-11 EP EP09100011.7A patent/EP2168974B1/de not_active Revoked
- 1997-08-11 CN CNB971960356A patent/CN1158300C/zh not_active Expired - Lifetime
- 1997-08-11 DE DE59713018T patent/DE59713018D1/de not_active Expired - Lifetime
- 1997-08-11 DK DK01250277.9T patent/DK1149840T5/da active
- 1997-08-11 ES ES97937562T patent/ES2175451T7/es active Active
- 1997-08-11 EP EP01250277.9A patent/EP1149840B2/de not_active Expired - Lifetime
- 1997-08-11 BR BR9711060A patent/BR9711060A/pt not_active IP Right Cessation
- 1997-08-11 DE DE59712991T patent/DE59712991D1/de not_active Expired - Lifetime
- 1997-08-11 HU HU9903089A patent/HU223106B1/hu active Protection Beyond IP Right Term
- 1997-08-11 PT PT97937562T patent/PT918791E/pt unknown
- 1997-08-11 JP JP50938998A patent/JP3333524B2/ja not_active Expired - Lifetime
- 1997-08-11 KR KR10-1999-7001166A patent/KR100473297B1/ko not_active Expired - Lifetime
- 1997-08-11 PL PL97331530A patent/PL187474B1/pl unknown
- 1997-08-11 SI SI9730790T patent/SI1149841T1/sl unknown
- 1997-08-11 EP EP97937562A patent/EP0918791B3/de not_active Expired - Lifetime
- 1997-08-11 PT PT01250278T patent/PT1149841E/pt unknown
- 1997-08-11 DE DE59706887T patent/DE59706887D1/de not_active Expired - Lifetime
- 1997-08-11 PT PT01250277T patent/PT1149840E/pt unknown
- 1997-08-11 AT AT01250277T patent/ATE420098T1/de active
- 1997-08-11 SK SK194-99A patent/SK283546B6/sk not_active IP Right Cessation
- 1997-08-11 PT PT91000117T patent/PT2168974E/pt unknown
- 1997-08-11 DK DK09100011.7T patent/DK2168974T3/da active
- 1997-08-11 CZ CZ0047099A patent/CZ297255B6/cs not_active IP Right Cessation
- 1997-08-11 EA EA199900153A patent/EA001947B1/ru not_active IP Right Cessation
- 1997-08-11 ES ES01250277T patent/ES2320626T5/es not_active Expired - Lifetime
- 1997-11-08 UA UA99031342A patent/UA55423C2/uk unknown
1998
- 1998-12-01 BG BG102976A patent/BG62776B1/bg unknown
1999
- 1999-01-29 IS IS4965A patent/IS2100B/is unknown
2000
- 2000-08-18 US US09/640,748 patent/US6933395B1/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
WO1998006738A1 (de)	1998-02-19
SK283546B6 (sk)	2003-09-11
DK0918791T3 (da)	2002-07-15
EP2168974A3 (de)	2013-03-06
ES2320626T3 (es)	2009-05-27
IS2100B (is)	2006-04-12
ATE420098T1 (de)	2009-01-15
DE59706887D1 (de)	2002-05-08
CA2261137C (en)	2005-03-15
EP1149840B2 (de)	2013-05-15
ES2175451T3 (es)	2002-11-16
ES2438941T1 (es)	2014-01-20
EP1149840A2 (de)	2001-10-31
EP1149840A3 (de)	2004-12-01
SI1149840T2 (sl)	2013-08-30
EP0918791B3 (de)	2012-01-18
EA001947B1 (ru)	2001-10-22
DK1149841T3 (da)	2010-03-08
EP1149841B1 (de)	2009-10-28
KR20000029939A (ko)	2000-05-25
PT2168974E (pt)	2014-08-26
DK1149840T4 (da)	2013-07-01
US6933395B1 (en)	2005-08-23
PL331530A1 (en)	1999-07-19
AU729149B2 (en)	2001-01-25
IS4965A (is)	1999-01-29
CZ297255B6 (cs)	2006-10-11
NZ333697A (en)	2000-08-25
TR199900262T2 (xx)	1999-03-22
ATE215557T1 (de)	2002-04-15
DE59713018D1 (de)	2009-12-10
DK1149840T3 (da)	2009-04-27
US6121465A (en)	2000-09-19
EP1149841A3 (de)	2004-12-01
CZ47099A3 (cs)	1999-05-12
AU4014497A (en)	1998-03-06
EP2168974A2 (de)	2010-03-31
CA2261137A1 (en)	1998-02-19
DE19633685C1 (de)	1997-10-09
PL187474B1 (pl)	2004-07-30
SI1149840T1 (sl)	2009-06-30
JP3333524B2 (ja)	2002-10-15
PT1149840E (pt)	2009-03-31
BG62776B1 (bg)	2000-07-31
DE59712991D1 (de)	2009-02-26
IL127963A0 (en)	1999-11-30
UA55423C2 (uk)	2003-04-15
SK19499A3 (en)	1999-10-08
EP1149840B1 (de)	2009-01-07
BG102976A (en)	1999-08-31
ATE446966T1 (de)	2009-11-15
EP0918791A1 (de)	1999-06-02
CN1158300C (zh)	2004-07-21
DK2168974T3 (da)	2014-08-11
HK1021190A1 (en)	2000-06-02
CN1223662A (zh)	1999-07-21
ES2438941T3 (es)	2014-07-21
SI0918791T1 (en)	2002-12-31
SI1149841T1 (sl)	2010-02-26
EP1149841A2 (de)	2001-10-31
KR100473297B1 (ko)	2005-03-07
EP0918791B1 (de)	2002-04-03
ES2320626T5 (es)	2013-09-05
IL127963A (en)	2004-06-20
BR9711060A (pt)	1999-08-17
HU223106B1 (hu)	2004-03-29
HUP9903089A3 (en)	2001-07-30
PT918791E (pt)	2002-09-30
EA199900153A1 (ru)	1999-06-24
EP2168974B1 (de)	2014-07-02
PT1149841E (pt)	2010-01-29
ES2335860T3 (es)	2010-04-06
EP0918791B8 (de)	2003-01-08
JP2000516226A (ja)	2000-12-05
ES2175451T7 (es)	2012-11-19

Publication	Publication Date	Title
DK1149840T4 (da)	2013-07-01	Fremgangsmåde til fremstilling af drospirenon
ATE371670T1 (de)	2007-09-15	Reinigung von neurotrophinen
PT1017659E (pt)	2005-09-30	Tetra-hidronaftalenos substituidos e compostos analogos
IL150698A0 (en)	2003-02-12	Processes for preparing clarithromycin polymorphs
TR200200460T2 (tr)	2002-06-21	Yeni fenilpiperazinler
NO985462D0 (no)	1998-11-23	Karbohydrat-derivater og fastfase-syntese derav
DK0934256T3 (da)	2002-12-02	Fremgangsmåde til fremstilling af cyanocinnamamider
BR0013709A (pt)	2002-05-07	Preparação de derivados de dibenzossuberenona através de desidrogenação catalìtica
MXPA02012053A (es)	2005-08-16	Procedimiento para la obtencion de 3,3,5-trimetilciclohexanol.
ATE268318T1 (de)	2004-06-15	Cycloalkylderivate und ihre synthese an fester phase
ES2183543T3 (es)	2003-03-16	Derivado de tiocolchicosida, su preparacion y su aplicacion en terapeutica.
DE69923958D1 (de)	2005-04-07	Konvergente synthese von alpha-aryl-beta-ketonitrilen
NO20000869D0 (no)	2000-02-22	Fremgangsmåte for fremstilling av 1-(cyklopentenyloksy-4- alkoksyfenyl)-4-oksocykloheksankarbonitril
ZA994944B (en)	2000-04-26	Catalyst for the hydrogenation of maleic acid to 1,4 butanediol.